This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Evangelou, A. Articles by Brown, T. J. Search for Related Content PubMed PubMed Citation Articles by Evangelou, A. Articles by Brown, T. J.

Loss of Coordinated Androgen Regulation in Nonmalignant Ovarian Epithelial Cells with BRCA1/2 Mutations and Ovarian Cancer Cells¹

Cancer and Blood Research Program, The Hospital for Sick Children [A. E., M. L.]; Division of Reproductive Science, The Samuel Lunenfeld Research Institute, Mt. Sinai Hospital [A. E., T. J. B.]; Divisions of Cancer Informatics [I. J., M. S.] and Gynecology Oncology [K. J. M., B. R.], Ontario Cancer Institute/Princess Margaret Hospital, University Health Network; and the Departments of Zoology [A. E., T. J. B.], Obstetrics and Gynecology [M. L., T. J. B.], Computer Science [I. J.], Medical Biophysics [M. L., I. J.], and Immunology [M. L.], University of Toronto, Toronto, Ontario M5G 1X5, Canada

Epidemiological studies have implicated androgens in the etiology/progression of epithelial ovarian cancer. Because normal and malignant ovarian epithelial cells are growth inhibited by transforming growth factor (TGF) ß, we tested the ability of 5-dihydrotestosterone (DHT) to modulate this response and the expression of TGF-ß receptor types I and II. Cells derived from the ovarian surface epithelium of women undergoing oophorectomy (n = 7) for nonovarian indications or with a germ-line BRCA1 or 2 mutation (n = 9), and from the ascitic fluid of patients with primary ovarian cancer (n = 8) were cultured with and without DHT. Cell proliferation after TGF-ß1 or vehicle treatment was determined, and transcripts for TGF-ß receptors were measured by quantitative reverse transcription-PCR. As low levels of androgen receptor were observed in the cultures, we also measured transcript levels for steroid receptor coactivators SRC-1, ARA70, and AIB1. TGF-ß1 inhibited growth in 12 of 13 cultures tested, and DHT generally reversed this effect, demonstrating that androgens can block TGF-ß-induced growth inhibition in both malignant and nonmalignant ovarian epithelial cells. Transcripts for TGF-ß receptors, SRC-1, and ARA70 were found to be coordinately regulated by androgen in control cells, but not in either malignant or BRCA1/2-positive cell cultures. These findings raise the possibility that by modulating steroid receptor coactivator expression, androgen might affect other hormonal responses and contribute to the initiation of ovarian cancer.

This article has been cited by other articles:

				P. C.K. Leung and J.-H. Choi Endocrine signaling in ovarian surface epithelium and cancer Hum. Reprod. Update, March 1, 2007; 13(2): 143 - 162. [Abstract] [Full Text] [PDF]

				N. Soleymanlou, I. Jurisica, O. Nevo, F. Ietta, X. Zhang, S. Zamudio, M. Post, and I. Caniggia Molecular Evidence of Placental Hypoxia in Preeclampsia J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4299 - 4308. [Abstract] [Full Text] [PDF]